3
Announcements
Trials
Browse
Landscape
Phase
Phase 1/2
1
Status
Unknown
1
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Conditions
Neoplasms
7
Breast Neoplasms
6
Colorectal Neoplasms
5
Prostatic Neoplasms
4
Head and Neck Neoplasms
4
Lung Neoplasms
3
Glioblastoma
3
Stomach Neoplasms
2
Pancreatic Neoplasms
2
Motor Activity
2
Malnutrition
2
Liver Neoplasms
2
Carcinoma, Non-Small-Cell Lung
2
Weight Loss
1
Uterine Cervical Neoplasms
1
Urinary Bladder Neoplasms
1
Upper Excretory Tract Tumors
1
Ulcer
1
Thrombosis
1
Stomatitis
1
Squamous Cell Carcinoma of Head and Neck
1
Small Cell Lung Carcinoma
1
Sleep Disorders, Circadian Rhythm
1
Sezary Syndrome
1
Seizures
1
Rectal Neoplasms
1
Radiodermatitis
1
Radiation Induced Oral Mucositis
1
Pulmonary Disease, Chronic Obstructive
1
Pulmonary Atelectasis
1
Interventions
Colonoscopy
2
Biopsy
2
polyethylene glycol 400
1
Thrombin Time
1
Surgical Tape
1
Standard of Care
1
Spectrum Analysis, Raman
1
Proctocolectomy, Restorative
1
Polyethylene Glycols
1
Oxygen
1
Neomycin
1
Metronidazole
1
Medical Marijuana
1
Laparoscopy
1
Indocyanine Green
1
Indigo Carmine
1
Hyperspectral Imaging
1
Glycols
1
Gastroscopy
1
Ethanol
1
Endoscopy
1
Dietary Fiber
1
Blood Specimen Collection
1
Benchmarking
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Unknown
×
Inflammatory Bowel Diseases
×
Standard of Care
×
Clear all
NCT06109961
2023-11-07
HYPNOTIC
Ottawa Hospital Research Institute
Phase 1/2
Unknown
40 enrolled